Drug repurposing against coronavirus disease 2019 (COVID-19): A review
Since December 2019, severe acute respiratory syndrome coronavirus 2 has been found to be the culprit in the coronavirus disease 2019 (COVID-19), causing a global pandemic. Despite the existence of many vaccine programs, the number of confirmed cases and fatalities due to COVID-19 is still increasin...
Saved in:
Main Authors: | Lianxiang Luo (Author), Qin Qiu (Author), Fangfang Huang (Author), Kaifeng Liu (Author), Yongqi Lan (Author), Xiaoling Li (Author), Yuge Huang (Author), Liao Cui (Author), Hui Luo (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2021-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Potential Therapeutic Effect of Traditional Chinese Medicine on Coronavirus Disease 2019: A Review
by: Qin Qiu, et al.
Published: (2020) -
Strategies for drug repurposing against coronavirus targets
by: Poppy O. Smith, et al.
Published: (2022) -
The correlation analysis between the appearance anxiety and personality traits of the medical staff on nasal and facial pressure ulcers during the novel coronavirus disease 2019 outbreak
by: Xiaodi Kong, et al.
Published: (2021) -
Repurposing carrimycin as an antiviral agent against human coronaviruses, including the currently pandemic SARS-CoV-2
by: Haiyan Yan, et al.
Published: (2021) -
A Review of Treatment of Coronavirus Disease 2019 (COVID-19): Therapeutic Repurposing and Unmet Clinical Needs
by: Po-Lin Chen, et al.
Published: (2020)